Author: Datasea Intelligent Technology Ltd.

Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device

August 11, 2026
Datasea Intelligent Technology Ltd. Announces CEO’s Intention to Purchase Up to US$1.0 Million of the Company’s Class A Ordinary Shares

June 16, 2026

Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device